22 November 2017
News and Views
Links and Services
The latest British Journal of Surgery reviews the benefits and risks of neoadjuvant chemoradiation for esophageal cancer.
Surgery alone for locally advanced oesophageal cancer is associated with low cure rates.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors